• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Belgium·Basic Materials·SCHD.BR
Share

Scheerders van Kerchove's Verenigde fabrieken nv Stocks

€ 340Last Updated 18.12.2024

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

€ 15.74M

€ 340
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Scheerders van Kerchove's Verenigde fabrieken nv manufactures and distributes building materials for residential and non-residential construction in Belgium and internationally. It offers a range of roofing and cladding products, such as façade panels, slates, facing bricks, corrugated panels, and architectonic concrete. The company was founded in 1905 and is based in Sint-Niklaas, Belgium.

Company Valuation

Greatly undervalued
7/7

From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

21.05.2026 15:00

Anthropic will pay nearly $45 billion for access to SpaceX supercomputers

21.05.2026 14:35

The Ebola outbreak has sent shares of biotech GeoVax skyrocketing. It's developing a vaccine

21.05.2026 14:12

Wedbush analyst predicted a Tesla and SpaceX merger in 2027

21.05.2026 12:20

SpaceX IPO will make Elon Musk the world's first and only trillionaire

21.05.2026 11:25

WHO reports hantavirus and a dangerous Ebola outbreak. Will this set off a new vaccine race?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026